ocd contemporary study: POTS Flashcards
(20 cards)
what was the aim of The Paediatric OCD Treatment Study (POTS)?
- evaluate three treatments for OCD in young people
- compare the effectiveness of CBT alone, drug treatment, and a combination of CBT & drug treatment
- assess which treatment is most effective for treating young people with OCD
- funded by the National Institute for Mental Health (USA) to find the best early intervention
what was the sample used in The Paediatric OCD Treatment Study (POTS)?
- 112 children, aged between 7 and 17 years old, with an average age of 11.7 years
- recruited from those diagnosed with OCD using DSM IV
- volunteer sample
how were the children’s OCD symptoms measured in The Paediatric OCD Treatment Study (POTS)?
- severity measured using CY-BOCS (Children’s Yale-Brown Obsessive-Compulsive Scale)
- only children with a score of 16 or above were included in the study
what were the inclusion and exclusion criteria for children in The Paediatric OCD Treatment Study (POTS)?
- children with comorbid disorders like Tourette’s and major depression were excluded to avoid interaction effects
- children with ADHD were included as long as they were on stable stimulant medication
- children were not on any anti-obsessional medication at the start of the study
how were participants allocated and what was the structure of The Paediatric OCD Treatment Study (POTS)?
- children randomly allocated to one of 4 groups:
- drugs only
- placebo pill only
- CBT-only
- combination of CBT and drug
- baseline measure taken using CY-BOCS and an interview
- study lasted 12 weeks
- each child had a specialist psychiatrist to monitor progress and offer support
what was the procedure for the drugs-only and placebo conditions in The Paediatric OCD Treatment Study (POTS)?
- children attended weekly for the first 6 weeks, then every other week (9 sessions total)
- kept a medication diary to track dosages
- dosages were adjusted as needed during clinical sessions
- parents helped monitor medication adherence
- any adverse reactions led to stopping the medication
what was the procedure for the CBT-only condition in The Paediatric OCD Treatment Study (POTS)?
- required 14 clinical sessions over 12 weeks
- based on a CBT manual
- involved psychological education, cognitive training, and mapping OCD target symptoms
- included exposure and response ritual prevention
- sessions included goal setting, weekly reviews, therapist-assisted practice, homework, and monitoring
what was the procedure for the combined condition in The Paediatric OCD Treatment Study (POTS)?
- involved both drug and CBT sessions
- sessions were time-linked and provided simultaneously
how were participants assessed during The Paediatric OCD Treatment Study (POTS)?
- ppts were assessed at weeks 4, 8, and 12
- assessments were done by independent evaluators trained to a reliable standard
- supervision and review of assessments were conducted to ensure reliability
what were the conclusions of The Paediatric OCD Treatment Study (POTS)?
- CBT led to a higher improvement rate than drugs, suggesting CBT should be the first line of treatment
- minimal gain from adding drugs to effective CBT
- drugs may compensate for less effective CBT therapy
what were the results of The Paediatric OCD Treatment Study (POTS)?
- 97 out of 112 ppts completed the study
- all conditions showed improvement at 12 weeks on the CY-BOCS, but placebo improvement wasn’t significant
- CBT-only condition: 39.3% entered remission (CY-BOCS score below 10)
- drugs-only condition: 21.4% entered remission
- remission rate rose marginally in the combined condition
strength - gen
- large sample size
- representative of the target population (children and young people with OCD)
weakness - gen
- the sample was mostly white (92%)
- the study was conducted in the USA, which may limit its generalisability to other cultures
weakness - reliability
- the study was conducted over 3 centres
- one centre had better results in the CBT-only condition
- this may have been due to the therapist effect, where some therapists were more proficient at delivering CBT
application
- the CBT and medication treatments used were acceptable to ppts and well-tolerated
- the treatments were highly practical, using well-established and easily accessible protocols (e.g., March and Mulle’s CBT manual)
- findings support the routine use of combined CBT-medication treatment
- this approach would benefit both young people with OCD and wider society
strengths - val
- assessors were blind to which condition the ppts were in, preventing biased evaluations
- ppts in the placebo condition were unaware the drug was not active
- therapists were also unaware of which condition the participants were in, ensuring unbiased treatment delivery
weaknesses - val
- not all procedures were rigorously standardised
- 12 ppts and clinicians knew combined-treatment ppts were receiving medication, meaning ‘masking’ was imperfect
- knowledge of group membership may have influenced expectations and outcomes
-
combined-treatment ppts completed more CBT sessions than those in the CBT-only group (14 vs. 12)
- combined group received a lower daily dose of medication compared to the sertraline-only group (133 mg vs. 170 mg)
- these differences make it harder to make valid comparisons between treatment groups
strength - ethics
- the lead researcher (John March) ensured confidentiality and data security
- written consent was obtained from all ppts (and at least one parent)
- ppts who received the placebo could choose a genuine treatment at the end of the study
- these ethical considerations improved the study’s credibility with ppts and the public
strength - reliability
- several techniques were used to increase reliability
- procedures were standardised (e.g., strict drug dose schedule, established CBT protocols)
- controls ensured similarity between groups
- both medication groups had regular meetings with a professional
- both sertraline and placebo groups took tablets they believed would help
- variations within groups were likely due to individual differences, and differences between groups were due to the treatments rather than procedural variations
weakness - ethics
- deception was used in the placebo condition, as ppts were unaware they were receiving a non-active treatment